Peripheral artery disease (PAD) leads to more than 400 leg amputations per day in the U.S. Kumar Madassery, MD, discussed the importance of increasing awareness and reaching patients before it is too late. 

When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing. 

The shields can significantly reduce radiation exposure, according to cardiologist David G. Rizik, MD. He said they also allow cardiologists, nurses and other cath lab employees to provide care without wearing lead aprons. 

Two new studies evaluated the long-term impact of choosing TAVR when low-risk patients present with severe aortic stenosis. 

The new-look robotics system can help specialists perform remote mechanical thrombectomies from bedside or as far as thousands of miles away. 

Researchers say their new analysis, based on five years of U.S. data, highlights just how important it is to keep post-TAVR PPMI rates to a minimum. 

Ken Rosenfield, MD, of Massachusetts General Hospital, and William Gray, MD, of Lankenau Heart Institute, detailed the long-term impact of a key policy shift. 

Interventional cardiologists have been anticipating this news for quite some time. The device, the first of its kind, provides an alternative treatment option to repeat PCI or cardiac surgery for patients with coronary ISR.